Side Effects of Drugs Annual

Erscheinungsjahr 2020
ISBN: 978-0-12-820330-9
Verlag: William Andrew Publishing

Buch, Englisch, 590 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 1770 g

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 42, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered in this new release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressants, Lithium, Drugs of Abuse, Hypnotics and Sedatives, Antipsychotic Drugs, Antiepileptics, Opioid Analgesics and Narcotic Antagonists, Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout, and much more.

Zielgruppe

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries.

Autoren/Hrsg.

Weitere Mitwirkende

Ray, Sidhartha D.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie

Inhaltsverzeichnis

1. Central nervous system stimulants and drugs that suppress appetite

Dushyant Kshatriya and Nicholas T. Bello

2. Antidepressant medications

Emily Leppien, Tamara Bystrak and Bennett Doughty

3. Lithium

Holly Lowe, Jason Bowell, Jaqueline Go, Taylor LaFrance, Ashley D. Riner, Sarah M. Arthur, Sidhartha D. Ray and Connie F. Rust

4. Drugs of abuse

Katelynn M. Mayberry, Jenna Bloemer and Sidhartha D. Ray

5. Drugs used in the treatment of Alzheimer's disease

Jenna Bloemer

6. Sedatives and hypnotics

Parna Haghparast, Michael Pondrom and Sidhartha D. Ray

7. Antipsychotic agents

Ashakumary Lakshmikuttyamma, Parna Haghparast, Emily Hajjar, Timothy Smith and Parisa Pooresfehani

8. Anti-epileptic medications

Cucnhat Phung Walker and Sidhartha D. Ray

9. Opioid analgesics and narcotic antagonists

Ashley Sowards, Michael G. O'Neil, Justin G. Kullgren and Jennifer M. Silva

10. Anti-inflammatory and antipyretic analgesics and drugs used in gout

Brittany Long and Mark E. Olah

11. General anesthetics and therapeutic gases

Mark Lavery and Alison Hall

12. Local anesthetics

Danielle D Pete and Manoranjan S D'Souza

13. Antihistamines (H1 receptor antagonists)

Cheryl K. Horlen and Johnathan Cuevas

14. Drugs that act on the respiratory tract

Dinesh Yogaratnam, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Daniel Havkins, Amy BW LaMothe and Ann M. Lynch

15. Positive inotropic drugs and drugs used in dysrhythmias

Kerry Anne Rambaran, Rebecca Tran and Saeed Alzghari

16. Beta adrenergic antagonists and antianginal drugs

Lindsey M. Stever, Lindsey Foltanski, Mallory L. Moore, Carrie Anderson and Brooklyn Nelson

17. Drugs acting on the cerebral and peripheral circulations

Keaton S. Smetana, Brian P. Goetz and Casey C. May

18. Antihypertensive drugs

Rebecca Kavanagh

19. Diuretics

Saeed Khaled Alzghari, Kerry Anne Rambaran and Sidhartha D. Ray

20. Metals and metal antagonists

Joshua P. Gray and Sidhartha D. Ray

21. Antiseptic drugs and disinfectants

Dirk W. Lachenmeier

22. Beta-lactams and tetracyclines

Rebecca A. Buckler, Meghan T. Mitchell and Samantha R. Phillips

23. Miscellaneous antibacterial drugs

Jason M. Cota and Taylor M. Benavides

24. Antiprotozoal

Bejoy Paul Maniara, Ian Wells and Sidhartha D. Ray

25. COVID-19 pandemic: Case studies and perspectives

Michael Liu

26. Antituberculosis and antileprosy medications

Igho J. Onakpoya

27. Antihelminthic drugs

Igho J. Onakpoya

28. Blood, blood components, plasma, and plasma products

Seohyun (Claudia) Choi, Michael Casias, Danielle Tompkins and Jimmy Gonzalez

29. Drugs that affect blood coagulation, fibrinolysis and hemostasis

Seohyun (Claudia) Choi, Jessica Wilczynski, Danielle Tompkins and Jimmy Gonzalez

30. Gastrointestinal drugs (Jan 2019-Dec 2019)

Lindsey Sellers Coppiano and Dianne May

31. Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs

Cucnhat Walker and Sidhartha D. Ray

32. Corticotrophins, corticosteroids, and prostaglandins

Jose Ruiz, Maya Watford, Essie Samuel, Sidhartha D. Ray and Vicky Modi

33. Sex hormones, related compounds and hormonal contraceptives including miscellaneous hormones

Ian Wells, Sandy Ezzet, Namarta Kalia, Kenneth Pawa and Sidhartha D. Ray

34. Thyroid hormones, iodine and iodides, and antithyroid drugs

Ian Wells, Sandy Ezzet, Namarta Kalia, Chana E. Shenas and Sidhartha D. Ray

35. Insulin and other hypoglycemic drugs

Laura A. Schalliol and Jasmine M. Pittman

36. Drugs that affect lipid metabolism

Amanda Phoenix, Charnicia E. Huggins and Kevin Pao

37. Radiological contrast agents and radiopharmaceuticals

Manoranjan S D'Souza, Rachel Miguel and Sidhartha D. Ray

38. Drugs used in ocular treatment

Robert S. Duszak, Emily R. Carr, Rajni K. Acharya and Lisa V. Stottlemyer

39. Complementary and alternative medicine

Renee A. Bellanger and Christina M. Seeger

40. Cytostatic agents

Adrienne T. Black, Daniel Zinkovsky, Shelly Ray and Sidhartha D. Ray

Über Autor(innen)

Ray, Sidhartha D.
Sidhartha D. Ray, PhD, FACN serves as a Senior Professor of Pharmaceutical and Biomedical Sciences at The Touro College of Pharmacy at Manhattan, New York. Prior to this he served as Professor of Pharmaceutical Sciences for nearly 2 decades at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University, New York, and as the founding chair of Pharmaceutical Science department at Manchester University College of Pharmacy, Indiana, USA. He has been in the health sciences academy for over 35 years mainly focusing on pharmacy teaching, research and service. Dr. Ray's research program focus on drug & chemical induced organ toxicology, mechanistic & molecular toxicology, adverse drug reaction mechanisms, side effects of a number of therapeutically relevant drugs and environmentally significant chemicals. Over the last two decades, Dr. Ray's seminal discoveries have provided clear understandings on the dynamic role of apoptosis, necrosis and necraptosis during organotoxic reactions and have influenced the development of safety measures for a stunning variety of xenobiotics, phytochemicals and nutraceuticals. He is internationally recognized as a leader in the scientific community and was one of the front runners in exploring mechanisms of drug and chemical-induced programmed and un-programmed cell death in in-vivo models. His landmark studies on the interplay of bcl-2, bcl-xl, p53, bad and bax during acetaminophen induced cell death and its prevention by grape seed proanthocyanidin extract has earned worldwide citations. His peer recognition and acknowledged service contributions are reflected by his election into multiple international professional organizations, such as the Society of Toxicology (SOT), Society of Free Radical Biology & Medicine (SFRBM), American Society of Pharmacology & Experimental Therapeutics (ASPET), American Association of Colleges of Pharmacy (AACP) and American College of Nutrition (ACN). Dr. Ray is an Associate Editor of Encyclopedia of Toxicology (3rd Ed, Elsevier, 2014), and serves on the editorial boards of multiple prestigious international journals, including 'Archives of Toxicology' and 'Oxidative Medicine & Cellular Longevity'. Based on his contributions to teaching, service and scholarship to health sciences in general, Dr. Ray received multiple prestigious awards, inc. the American Academy of Clinical Toxicology's national research award (1996), 'Fellow of the American College of Nutrition' honor in 1999, David Newton Award for Excellence in Teaching Pharmacy (2005), the Biennial Abraham Krasnoff Memorial Award for Lifetime Scholarly Achievement (2008), Arnold & Marie Schwartz College of Pharmacy & Health Science's 'Wall-of-Fame' honor (2011), the Society of Toxicology's 'Undergraduate Educator of the Year' national award (2013), and the Manchester University's 'Outstanding Scholar of the Year' award (2014). He currently serves on the SOT-NIH-NLM's joint Toxlearn Project, SOT Undergraduate Task Force (2007 - present), and has previously served on the SOT's Education Committee (2007 - 2010). In his lifetime, Dr. Ray has mentored research to numerous PharmD, MS, MD and PhD students in a number of areas of toxicology and biomedical sciences, made seminal contributions to the fields of pharmacology, toxicology, free radical biology, anticancer mechanism, phytochemicals, nutraceuticals & dietary supplements, and molecular safety sciences. Dr. Ray loves to promote 'Lifelong Learning' strategies to his students and clearly models his beliefs day in and day out. Visit URL: www.sidhartharay.com/ for more details.